In addition to modulation of the PM, Minerval also specifically modulates the activity of sphingomyelin synthase (SMS1), leading to an increased concentration of sphingomyelin (SM) in cancer cells but not in non-cancer cells, in which SM levels are already high [10]. The gene discussed is SGMS1; the disease is cancer.